Diagnostic performance of glycated haemoglobin (HbA1c) for diabetes mellitus in dogs. (April 2023)
- Record Type:
- Journal Article
- Title:
- Diagnostic performance of glycated haemoglobin (HbA1c) for diabetes mellitus in dogs. (April 2023)
- Main Title:
- Diagnostic performance of glycated haemoglobin (HbA1c) for diabetes mellitus in dogs
- Authors:
- Oikonomidis, I.L.
Tsouloufi, T.K.
Tzenetidou, Z.
Ceron, J.J.
Tvarijonaviciute, A.
Konstantinidis, A.O.
Soubasis, N. - Abstract:
- Abstract: The objective of this study was to determine the diagnostic performance of glycated haemoglobin (HbA1c) for canine diabetes mellitus (DM) and compare it with that of serum fructosamine. Aliquots of blood samples collected for diagnostic purposes from adult dogs were used. HbA1c was measured using a previously validated capillary electrophoresis assay. The dogs were allocated into four groups: (1) DM; (2) hyperadrenocorticism (HAC); (3) long-term corticosteroid therapy (CST); and (4) various chronic diseases (VD). In total, 88 dogs were included as follows: DM ( n = 11), HAC ( n = 10), CST ( n = 14), and VD ( n = 53). Fructosamine was measured in all four groups as follows: DM ( n = 6), HAC ( n = 7), CST ( n = 9), and VD ( n = 42). Median (range) serum glucose concentration was higher ( P < 0.001) in the DM group (22.8 mmol/L; range, 15.6–29.3 mmol/L) compared to HAC (5.9 mmol/L; range, 4.2–6.8 mmol/L), CST (5.6 mmol/L; range, 4.3–23.3 mmol/L), and VD (5.5 mmol/L; range, 4.1–9.4 mmol/L) groups. Mean (± standard deviation) HbA1c was higher ( P < 0.001) in the DM group (6.3% ± 1.5%) compared to HAC (1.9% ± 0.5%), CST (1.7% ± 0.5%), and VD (1.9% ± 0.5%) groups. All diabetic dogs and none of the other dogs had HbA1c levels above the cut-off value for DM (3.3%), indicating an accuracy of 100% in diagnosing DM. Significant differences ( P < 0.01) were observed in median fructosamine between the DM group (389 μmol/L; range, 348–865 μmol/L) and the HAC (306Abstract: The objective of this study was to determine the diagnostic performance of glycated haemoglobin (HbA1c) for canine diabetes mellitus (DM) and compare it with that of serum fructosamine. Aliquots of blood samples collected for diagnostic purposes from adult dogs were used. HbA1c was measured using a previously validated capillary electrophoresis assay. The dogs were allocated into four groups: (1) DM; (2) hyperadrenocorticism (HAC); (3) long-term corticosteroid therapy (CST); and (4) various chronic diseases (VD). In total, 88 dogs were included as follows: DM ( n = 11), HAC ( n = 10), CST ( n = 14), and VD ( n = 53). Fructosamine was measured in all four groups as follows: DM ( n = 6), HAC ( n = 7), CST ( n = 9), and VD ( n = 42). Median (range) serum glucose concentration was higher ( P < 0.001) in the DM group (22.8 mmol/L; range, 15.6–29.3 mmol/L) compared to HAC (5.9 mmol/L; range, 4.2–6.8 mmol/L), CST (5.6 mmol/L; range, 4.3–23.3 mmol/L), and VD (5.5 mmol/L; range, 4.1–9.4 mmol/L) groups. Mean (± standard deviation) HbA1c was higher ( P < 0.001) in the DM group (6.3% ± 1.5%) compared to HAC (1.9% ± 0.5%), CST (1.7% ± 0.5%), and VD (1.9% ± 0.5%) groups. All diabetic dogs and none of the other dogs had HbA1c levels above the cut-off value for DM (3.3%), indicating an accuracy of 100% in diagnosing DM. Significant differences ( P < 0.01) were observed in median fructosamine between the DM group (389 μmol/L; range, 348–865 μmol/L) and the HAC (306 μmol/L; range, 167–348 μmol/L) and the VD (316 μmol/L; range, 189–500 μmol/L) groups. Fructosamine had an accuracy of 84.4% for the diagnosis of DM. When used for the diagnosis of canine DM, HbA1c measured with this specific assay had excellent diagnostic accuracy and was superior to serum fructosamine. Highlights: Glycated haemoglobin had 100% accuracy for diagnosing canine diabetes mellitus. Accuracy of fructosamine for the diagnosis of canine diabetes mellitus was 84.4%. Glycated haemoglobin had superior diagnostic performance compared to fructosamine. … (more)
- Is Part Of:
- Veterinary journal. Volume 294(2023)
- Journal:
- Veterinary journal
- Issue:
- Volume 294(2023)
- Issue Display:
- Volume 294, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 294
- Issue:
- 2023
- Issue Sort Value:
- 2023-0294-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-04
- Subjects:
- Canine -- Fructosamine -- Hyperglycaemia -- Ketoamine -- Prediabetes
Veterinary medicine -- Periodicals
636 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10900233 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tvjl.2023.105958 ↗
- Languages:
- English
- ISSNs:
- 1090-0233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9228.600000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26770.xml